Exosomes: Effectual players in rheumatoid arthritis

Autoimmun Rev. 2020 Jun;19(6):102511. doi: 10.1016/j.autrev.2020.102511. Epub 2020 Mar 12.

Abstract

Rheumatoid arthritis is a well-known chronic inflammatory joint disorder. It encompasses systemic inflammation, autoimmunity and development of several joint abnormalities leading to the lifelong disability and increased mortality. Exosomes are nano-sized (30-100 nm) mammalian extracellular particles with essential properties to regulate biological processes and cellular signaling by transferring protein and genetic materials. Understanding the diversity in the exosomal contents and their corresponding targets may contribute to better recognition of the processes that are implicated in the development and progression of diseases such as autoimmune disorders. Exosomes may act as a potential biomarker for the diagnosis of autoimmune disorders. In the present review, we aimed to bring together the relevant evidence on the biology of exosomes in rheumatoid arthritis, and also discuss the recent findings regarding the diagnostic, prognostic and therapeutic promise of these nanoparticles.

Keywords: Cell signaling; Exosome, rheumatoid arthritis; Inflammation.

Publication types

  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid*
  • Biomarkers
  • Exosomes*
  • Humans
  • Inflammation

Substances

  • Biomarkers